Resources:
On the 23rd of October, between 15:00-16:30 CEST, RWE4Decisions hosted its last webinar for 2024: “HTA/Payer Collaboration in the Nordics – The Role of Real-World Evidence”.
Speakers explored the creation and operation of the Joint Nordic HTA Bodies (JNHB) collaboration, how it evolved from FINOSE to JNHB, and how joint reports are taken up locally.
Chief Executive Officer, Silvi.ai / Professor, Ghent University
Secretary General, European Confederation of Pharmaceutical Entrepreneurs
Medical Assessor, Chief Consultant, Danish Medicines Council (DMC)
Medical Assessor, Dental and Pharmaceutical Benefits Agency (TLV)
Professor of personalised cancer medicine / Chief physician, University of Helsinki
Biostatistical Chief Consultant, Danish Medicines Council (DMC)
Access & Value FIND Cluster Lead and Managing Director, Pfizer Denmark
Public Webinar: From Policy to Practice: EHDS Implementation to Support Better Real-World Evidence for HTA/Payers
RWE4Decisions Symposium: Developing Real-World Evidence to Deliver Innovation in HTA
Public Webinar: Can Endpoints from Digital Technology Provide Meaningful Outcomes for HTA?
